The lawsuits accuse drug makers of overstating the benefits of opioids while downplaying the risks. Photograph: Eric Baradat/AFP via Getty

Four large drug companies reached a last-minute $260 million (€233 million) legal settlement over their role in the US opioid addiction epidemic, aver(...)

The employers’ representative group is to begin a three part series of debates in which Ireland’s European election candidates will be put through their paces on the issues. Photograph: Ibec

MONDAY Results: Trinity Biotech, Intercept Pharmaceuticals, Liberty Global, Hertz Global, Pappa John’s. Indicators: Euro zone retail sales (Mar), (...)

Immatics Biotechnologies chairman Peter Chambre and Alkermes director Shane Cooke are to join the board of UDG Healthcare as non-executive directors. Photograph: David Sleator

Healthcare services provider UDG Healthcare has appointed two new non-executive directors to its board. Immatics Biotechnologies chairman Peter Chamb(...)

 EpiPen allergy treatment pens  manufactured by Mylan. Photograph:   ReuterS/Jim Bourg

Mylan on Wednesday cut its forecasts for this year and next as eroding prices for generic drugs and challenges getting new products approved in the US(...)

A screen displays  the IBEX35 index at Madrid’s stock exchange market in Madrid, Spain. Photograph: EPA/Fernando Alvarado

A raft of well-received updates and a recovery in resources stocks helped European shares rebound from the previous session’s slight losses, ending a(...)

Pharma group Endo International reported an 18.6 per cent rise in quarterly revenue, driven by higher demand for generic drugs it acquired through its(...)

The Iseq’s bigger companies had mixed fortunes with Ryanair shares down 0.5 per cent.  Photograph: Nick Ansell/PA Wire

Most European and US markets were ahead yesterday, with the S&P 500 Index at a four-month high, as investors shook off oil’s losses on failed out(...)

Shire fell as much as 4.4 per cent and was down 3.3 per cent in early afternoon trading in London.

Pharma group Shire fell the most in a month as investors, who pummelled Valeant Pharmaceuticals stock, began to shun other specialty drugmakers. Val(...)

Valeant shares fell the most in four years after politicians asked to subpoena the company for documents relating to drug price increases

Valeant Pharmaceuticals continued to lose ground yesterday after the company was targeted by US Democrats over rising drug prices. Valeant shares shed(...)

Valeant Pharmaceuticals, the Canadian drugmaker known for its serial acquisitions, reported first-quarter profit that topped analysts’ estimates and r(...)

  • 1
  • 2
  • Next
  • Last »